跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PENTACEL
Authorized
STANDARD
PENTACEL
Sanofi Pasteur Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c2feb0be70dc7b25
Company
Sanofi Pasteur Limited
Type
Standard
Approval Details
Approval Id
c2feb0be70dc7b25
Drug Approval Canada Name
PENTACEL
Product Name
PENTACEL
Status
Marketed
Status Date
2024-05-06
Original Market Date
2024-05-06
Din
02534797
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07CA06 DIPHT-HEMOPH INFLUEN B-PERTUSS-POLIO-TETANUS
Atc Name
j 07 ca 06
Aig Number
1166043001
Company Name
Sanofi Pasteur Limited
Company Address
1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Company Detail Path
/organization/sanofi-pasteur-limited
Company Information
Pharmaceutical Company Name
Sanofi Pasteur Limited
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
1755 Steeles Ave W
Active Ingredients
FILAMENTOUS HAEMAGGLUTININ
20 MCG / 0.5 ML
FIMBRIAE
5 MCG / 0.5 ML
DIPHTHERIA TOXOID
15 LF / 0.5 ML
PERTUSSIS TOXOID
20 MCG / 0.5 ML
PERTACTIN
3 MCG / 0.5 ML
TETANUS TOXOID
5 LF / 0.5 ML
TETANUS PROTEIN
30 MCG / 0.5 ML
HAEMOPHILUS INFLUENZAE TYPE B-PRP
10 MCG / 0.5 ML
POLIOVIRUS TYPE 2 MEF1 (INACTIVATED)
7 UNIT / 0.5 ML
POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)
29 UNIT / 0.5 ML
POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED)
26 UNIT / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c2feb0be70dc7b25
Type
Standard
Back to Health Canada Approvals
PENTACEL - Health Canada Drug Approval Details